Acute chest pain (ACP) is a common symptom that often presents a diagnostic challenge to clinicians due to its broad differential diagnosis. The potential causes range from benign conditions to life-threatening diseases such as acute coronary syndrome (ACS). Therefore, a comprehensive approach to diagnose and manage ACP is critical.
When a patient presents with ACP, the initial assessment should include a thorough history, physical examination, and electrocardiogram. Risk stratification is crucial in guiding management. Tools such as the HEART score can aid in identifying high-risk patients who may benefit from hospital admission and further cardiac evaluation.
Diagnostic testing is an integral part of the ACP evaluation. In addition to electrocardiogram, cardiac biomarkers, particularly troponins, have a key role in diagnosing ACS. Imaging studies such as chest X-ray or CT angiography may be necessary to rule out non-cardiac causes of chest pain.
Management should be tailored to the underlying cause of ACP. For suspected ACS, early reperfusion therapy is the standard of care. Non-cardiac causes of chest pain may require different treatment approaches, such as gastrointestinal therapy for gastroesophageal reflux disease or analgesia for musculoskeletal pain.
Follow-up care is essential to ensure resolution of symptoms and to implement preventive measures. Lifestyle modifications and pharmacotherapy may be indicated to reduce the risk of future cardiac events in patients with coronary artery disease.
ACP is a complex clinical issue that requires a comprehensive approach for effective diagnosis and management. Careful initial assessment, appropriate diagnostic testing, targeted management strategies, and diligent follow-up care are all vital components of this approach. By adopting such a comprehensive approach, clinicians can provide optimal care for patients presenting with ACP and potentially prevent severe cardiac events.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation